UnknownNot Applicable

Prevalence, Clinical Features and Risk Factors of Cirrhotic Cardiomyopathy Assessed by Two-dimensional Speckle Tracking Imaging

China200 participantsStarted 2020-11-01

Plain-language summary

The purpose of this study is to assess the prevalence of cirrhotic cardiomyopathy in patients with cirrhosis, and to analyze the correlation between the severity of cirrhosis and cardiac dysfunction. To investigate the risk factors for cirrhotic cardiomyopathy, and raise clinicians' awareness of cirrhotic cardiomyopathy, early assessment and intervention to improve long-term outcomes in patients with cirrhosis.

Who can participate

Age range18 Years – 75 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * The clear diagnosis of cirrhosis in patients caused by various reasons Exclusion Criteria: * History of cardiovascular disease * Diabetes * High blood pressure * Hepatocellular carcinoma (HCC) or other malignant tumors * Patients with the chronic obstructive pulmonary disease * Thyroid diseases * Severe infection in the last 2 weeks * History of liver transplantation and/or TIPS surgery * Presence of stage 3 or above chronic kidney disease or acute chronic kidney disease * Pregnant women * Did not sign the informed consent form and refused to participate

What they're measuring

cirrhotic cardiomyopathy

Timeframe: Within 48 hours after hospitalization

Trial details

NCT IDNCT04969055

SponsorQilu Hospital of Shandong University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2022-06-30

View on ClinicalTrials.gov More Liver Cirrhosis trials